Outcomes of Ibrutinib (Ibr) Therapy in Ibr-Naïve Patients (pts) with Chronic Lymphocytic Leukemia (CLL) Progressing after Venetoclax (Ven)Jennifer R. Brown, William G. Wierda, Julie Chang et al.|Blood|2019Cited by 13